Paratek Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2011 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Paratek Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2011 to Q2 2023.
  • Paratek Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 57.3M shares, a 8.03% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 54.4M shares, a 12.3% increase from 2021.
  • Paratek Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 48.4M shares.
  • Paratek Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2012 was 17.1M shares, a 26% increase from 2011.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 57.3M +4.26M +8.03% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 56.9M +4.75M +9.12% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 54.4M +5.97M +12.3% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 55.2M +5.95M +12.1% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 53M +4.08M +8.33% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 52.1M +5.49M +11.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 48.4M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 49.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 48.9M +5.32M +12.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 46.7M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q2 2020 43.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q3 2013 18.8M -450K -2.34% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-07
Q4 2012 18.6M +4.23M +29.4% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 19.2M +5.71M +42.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 17.1M +3.57M +26.4% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 13.9M +464K +3.45% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 14.4M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-12
Q3 2011 13.5M Jul 1, 2011 Sep 30, 2011 10-K 2013-03-12
Q2 2011 13.5M Apr 1, 2011 Jun 30, 2011 10-K 2013-03-12
Q1 2011 13.5M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.